Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial
G. Janoray, Y. Pointreau, M. Alfonsi, C. Sire, L. Geoffrois, D. De Raucourt, É. Bardet, Marie-Hélène Calais, P. Garaud, G. Calais
Topics & Concepts
MedicineCetuximabHypopharyngeal cancerDocetaxelRadiation therapyChemoradiotherapyFluorouracilCisplatinInternal medicineInduction chemotherapyChemotherapyLarynxLaryngectomyClinical endpointConfidence intervalConcomitantSurgeryCancerOncologyRandomized controlled trialColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentVoice and Speech Disorders